Cargando…

The somatic mutation landscape of Chinese Colorectal Cancer

Colorectal cancer (CRC) is the fifth leading cause of cancer-related death in China. The incidence of Chinese CRC has increased dramatically with the changes of dietary and lifestyle. However, the genetic landscape of Chinese colorectal cancer mutation is still poorly understood. In this study, we h...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ma, Rong, Jing, Changwen, Zhang, Yuan, Cao, Haixia, Liu, Siwen, Wang, Zhuo, Chen, Dan, Zhang, Junying, Wu, Yang, Wu, Jianzhong, Feng, Jifeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2020
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6959081/ https://www.ncbi.nlm.nih.gov/pubmed/31956350 http://dx.doi.org/10.7150/jca.37017

Ejemplares similares

Long noncoding RNA and mRNA profiling in cetuximab‐resistant colorectal cancer cells by RNA sequencing analysis
por: Jing, Changwen, et al.
Publicado: (2019)

Cancer-associated changes of emotional brain network in non-nervous system metastatic non-small cell lung cancer patients: a structural connectomic diffusion tensor imaging study
por: Liu, Siwen, et al.
Publicado: (2020)

CLASRP oncogene as a novel target for colorectal cancer
por: Gu, Quan, et al.
Publicado: (2023)

LXR ligands induce apoptosis of EGFR-TKI-resistant human lung cancer cells in vitro by inhibiting Akt-NF-κB activation
por: Liu, Siwen, et al.
Publicado: (2018)

MEK inhibitor enhanced the antitumor effect of oxaliplatin and 5-fluorouracil in MEK1 Q56P-mutant colorectal cancer cells
por: Jing, Changwen, et al.
Publicado: (2019)

Cytokine-induced killer cells as a feasible adoptive immunotherapy for the treatment of lung cancer
por: Chen, Dan, et al.
Publicado: (2018)

Liver X receptor agonist T0901317 reverses resistance of A549 human lung cancer cells to EGFR‐TKI treatment
por: Cao, Haixia, et al.
Publicado: (2016)

Nedaplatin reduces multidrug resistance of non-small cell lung cancer by downregulating the expression of long non-coding RNA MVIH
por: Jing, Changwen, et al.
Publicado: (2020)

The landscape of somatic mutation in sporadic Chinese colorectal cancer
por: Liu, Zhe, et al.
Publicado: (2018)

Comparison of droplet digital PCR and direct Sanger sequencing for the detection of the BRAF (V600E) mutation in papillary thyroid carcinoma
por: Wang, Zhuo, et al.
Publicado: (2019)

Serum VEGF levels as a predictor of recurrence in patients with advanced‑stage esophageal squamous cell carcinoma following curative esophagectomy followed by chemotherapy or concurrent radiotherapy
por: Xu, Heng, et al.
Publicado: (2023)

Next-generation sequencing-based detection of EGFR, KRAS, BRAF, NRAS, PIK3CA, Her-2 and TP53 mutations in patients with non-small cell lung cancer
por: Jing, Changwen, et al.
Publicado: (2018)

The somatic mutation landscape of premalignant colorectal adenoma
por: Lin, Shu-Hong, et al.
Publicado: (2018)

Monoclonal antibody AC10364 inhibits cell proliferation in 5-fluorouracil resistant hepatocellular carcinoma via apoptotic pathways
por: Wu, Jianzhong, et al.
Publicado: (2019)

Comparison of nedaplatin-based versus cisplatin-based chemotherapy for advanced non-small cell lung cancer among East Asian populations: A meta-analysis
por: Liu, Yun, et al.
Publicado: (2015)

Hypermethylation of heparanase 2 promotes colorectal cancer proliferation and is associated with poor prognosis
por: Zhang, Hui, et al.
Publicado: (2021)

Identification of serum proteins and multivariate models for diagnosis and therapeutic monitoring of lung cancer
por: Ma, Rong, et al.
Publicado: (2017)

Serum Platelet-Derived Growth Factor Is Significantly Lower in Patients with Lung Cancer and Continued to Decrease After Platinum-Based Chemotherapy
por: Ma, Rong, et al.
Publicado: (2020)

Long noncoding RNAs predict the survival of patients with colorectal cancer as revealed by constructing an endogenous RNA network using bioinformation analysis
por: Zhang, Hui, et al.
Publicado: (2019)

Improved ataxia telangiectasia mutated kinase inhibitor KU60019 provides a promising treatment strategy for non-invasive breast cancer
por: ZHU, YING, et al.
Publicado: (2014)

Comparison of somatic mutation landscapes in Chinese versus European breast cancer patients
por: Zhu, Bin, et al.
Publicado: (2021)

CRNDE mediated hnRNPA2B1 stability facilitates nuclear export and translation of KRAS in colorectal cancer
por: Lu, Ya, et al.
Publicado: (2023)

Efatutazone and T0901317 exert synergistically therapeutic effects in acquired gefitinib‐resistant lung adenocarcinoma cells
por: Ni, Jie, et al.
Publicado: (2018)

Uncovering the Profile of Somatic mtDNA Mutations in Chinese Colorectal Cancer Patients
por: Wang, Cheng-Ye, et al.
Publicado: (2011)

Comprehensive characterization of CRC with germline mutations reveals a distinct somatic mutational landscape and elevated cancer risk in the Chinese population
por: Yao, Jianfei, et al.
Publicado: (2022)

Domain landscapes of somatic mutations in cancer
por: Nehrt, Nathan L, et al.
Publicado: (2012)

The somatic mutation landscape of the human body
por: García-Nieto, Pablo E., et al.
Publicado: (2019)

Colorectal cancer–associated T cell receptor repertoire abnormalities are linked to gut microbiome shifts and somatic cell mutations
por: Cao, Yuan, et al.
Publicado: (2023)

The evolving landscape of prostate cancer somatic mutations
por: Cotter, Kellie, et al.
Publicado: (2022)

The landscape of somatic mutations in lymphoblastoid cell lines
por: Caballero, Madison, et al.
Publicado: (2023)

The landscape of somatic mutations in lymphoblastoid cell lines
por: Caballero, Madison, et al.
Publicado: (2023)

In Vitro and in Vivo Efficacy of NBDHEX on Gefitinib-resistant Human Non-small Cell Lung Cancer
por: Sha, Huanhuan, et al.
Publicado: (2020)

Detection of serum VEGF and MMP-9 levels by Luminex multiplexed assays in patients with breast infiltrative ductal carcinoma
por: ZHANG, JUNYING, et al.
Publicado: (2014)

Circulating tumor DNA detection: A potential tool for colorectal cancer management
por: Li, Huizi, et al.
Publicado: (2019)

MicroRNAs as biomarkers for the progression and prognosis of colon carcinoma
por: Zhang, Hui, et al.
Publicado: (2018)

Whole-Exome Sequencing Characterized the Landscape of Somatic Mutations and Pathways in Colorectal Cancer Liver Metastasis
por: Feng, Liuxing, et al.
Publicado: (2019)

The Somatic Mutation Landscape and RNA Prognostic Markers in Stomach Adenocarcinoma
por: Zhang, Xiulei, et al.
Publicado: (2020)

The Somatic Mutational Landscape of Mismatch Repair Deficient Prostate Cancer
por: Fang, Bangwei, et al.
Publicado: (2023)

CDCA4 suppresses epithelial–mesenchymal transtion (EMT) and metastasis in Non-small cell lung cancer through modulating autophagy
por: Xu, Chenxin, et al.
Publicado: (2021)

Integrating Somatic Mutations for Breast Cancer Survival Prediction Using Machine Learning Methods
por: He, Zongzhen, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0u502i0a35erkr1jnjg6kqht67